Canada Cell and Gene Therapy Manufacturing QC Market Size & Outlook, 2025-2028
Canada Cell and Gene Therapy Manufacturing QC Market Size
According to a Straits Research analysis, the Canada Cell and Gene Therapy Manufacturing QC Market was valued at USD 70.79 Million in 2024. It is projected to reach USD 158.95 Million by 2028, expanding at a CAGR of 22.5% during the forecast period. Primary industries fueling this demand relate primarily to healthcare and biotechnology, focusing on disease treatments and preventive care solutions. Key drivers include emerging genomic technologies, advancements in precision medicine, and increased R&D activities. Moreover, sustainable manufacturing and green gene technology are gaining traction, with potential for further development and investment. The country's dedication to consistently adapt to technological advancements indicates a promising trajectory for Canada in maintaining a strong presence within this evolving market.
Source: Straits Research Analysis Company Publications, Primary Interviews.
Canada Cell and Gene Therapy Manufacturing QC Market Highlights
- Cell Therapy held the leading position among Therapy Type segments in 2024, based on market size.
- Gene Therapy is projected to post the fastest growth rate, sustaining its position as the most attractive Therapy Type segment during the forecast horizon.
- As of 2024, Canada held 3.17% of the global cell and gene therapy manufacturing qc market size.
- By 2028, United States is anticipated to capture the largest share of the global cell and gene therapy manufacturing qc market.
- In North America, United States is expected to lead the regional cell and gene therapy manufacturing qc market size by 2028.
- Canada will remain the fastest-growing market in North America, reaching USD 24106 Million by 2028.
- 📊 Preview Report Scope and Structure – Gain immediate visibility into key topics, market segments, and data frameworks covered.
- 📥 Evaluate Strategic Insights – Access selected charts, statistics, and analyst-driven commentary derived from the final report deliverables.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2024 |
| Study Period | 2021-2028 |
| Historical Period | 2021-2023 |
| Forecast Period | 2025-2028 |
| Market Size In 2024 | USD 70.79 Million |
| Market Size In 2028 | USD 158.95 Million |
| Largest segment | Cell Therapy |
| Fastest segment | Gene Therapy |
| Units | Revenue in USD Million |
| CAGR | 22.5% (2025-2028) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
Canada Cell and Gene Therapy Manufacturing QC Market Share By Therapy Type
Segmentation Covered
| Segments | Sub Segments |
|---|---|
| Therapy Type |
|
| Cell Therapy |
|
| CAR-T |
|
| Gene Therapy |
|
| Viral |
|
| Scale |
|
| Mode |
|
| Workflow |
|
| Process |
|
| End User |
|
| Pharmaceutical Companies |
|
| Biopharmaceutical / Biotechnological Companies |
|
| Contract Manufacturing Organizations |
|
| Technology Type |
|
Canada Cell and Gene Therapy Manufacturing QC Market By Therapy Type 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Canada Cell and Gene Therapy Manufacturing QC Market By Cell Therapy 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Canada Cell and Gene Therapy Manufacturing QC Market By CAR-T 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Canada Cell and Gene Therapy Manufacturing QC Market By Gene Therapy 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Canada Cell and Gene Therapy Manufacturing QC Market By Viral 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Canada Cell and Gene Therapy Manufacturing QC Market By Scale 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Canada Cell and Gene Therapy Manufacturing QC Market By Mode 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Canada Cell and Gene Therapy Manufacturing QC Market By Workflow 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Canada Cell and Gene Therapy Manufacturing QC Market By Process 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Canada Cell and Gene Therapy Manufacturing QC Market By End User 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Canada Cell and Gene Therapy Manufacturing QC Market By Pharmaceutical Companies 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Canada Cell and Gene Therapy Manufacturing QC Market By Biopharmaceutical / Biotechnological Companies 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Canada Cell and Gene Therapy Manufacturing QC Market By Contract Manufacturing Organizations 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Canada Cell and Gene Therapy Manufacturing QC Market By Technology Type 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
